Role of transcriptional and posttranscriptional regulation of methionine adenosyltransferases in liver cancer progression

Hepatology

Volumn 56, Issue 1, 2012, Pages 165-175

  Frau, Maddalena ^a   Tomasi, Maria L ^a   Simile, Maria M ^a   Demartis, Maria I ^a   Salis, Fabiana ^a   Latte, Gavinella ^a   Calvisi, Diego F ^a   Seddaiu, Maria A ^a   Daino, Lucia ^a   Feo, Claudio F ^a   Brozzetti, Stefania ^b   Solinas, Giuliana ^a   Yamashita, Satoshi ^c   Ushijima, Toshikazu ^c   Feo, Francesco ^a   Pascale, Rosa M ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; HUR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; METHIONINE ADENOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; RIBONUCLEOPROTEIN; S ADENOSYLMETHIONINE; TRANSCRIPTION FACTOR E2F1; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DEACETYLATION; DNA METHYLATION; DOWN REGULATION; GENE OVEREXPRESSION; GENE SWITCHING; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; BINDING SITES; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LIVER; LIVER NEOPLASMS; METHIONINE ADENOSYLTRANSFERASE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RATS; RATS, INBRED BN; RATS, INBRED F344; RNA, MESSENGER; S-ADENOSYLMETHIONINE; STATISTICS, NONPARAMETRIC; TRANSCRIPTIONAL ACTIVATION; TUMOR CELLS, CULTURED;

EID: 84863521166     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25643     Document Type: Article

References (45)

1. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 2007: 27: 55-76.
2. Calvisi DF, Pinna F, Ladu S, Pellegrino R, Muroni MR, Simile MM, et al. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for human disease. Carcinogenesis 2008; 29: 1639-1647.
3. Calvisi DF, Pinna F, Meloni F, Ladu S, Pellegrino R, Sini M, et al. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated-kinase-mediated control of growth in human hepatocellular carcinoma. Cancer Res 2008; 68: 4192-4200.
4. Calvisi DF, Pinna F, Ladu S, Pellegrino R, Sanna V, Sini M, et al. Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control. Int J Cancer 2008; 123: 2057-2064.
5. Calvisi DF, Pinna F, Ladu S, Pellegrino R, Simile MM, Frau M, et al. Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC. Gut 2009; 58: 679-687.
6. Calvisi DF, Simile MM, Ladu S, Frau M, Tomasi ML, Demartis MI, et al. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53. HEPATOLOGY 2011; 53: 1226-1236.
7. Frau M, Ladu S, Calvisi DF, Simile MM, Bonelli P, Daino L, et al. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype. J Hepatol 2011; 55: 111-119.
8. Pascale RM, Simile MM, De Miglio MR, Muroni MR, Calvisi DF, Asara G, et al. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis. HEPATOLOGY 2002; 35: 1341-1350.
9. Calvisi DF, Ladu S, Pinna F, Frau M, Tomasi ML, Sini M, et al. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis. Gastroenterology 2009; 137: 1816-1826.
10. Calvisi DF, Pinna F, Ladu S, Muroni MR, Frau M, Demartis I, et al. The degradation of cell cycle regulators by SKP2/CKS1 ubiquitin ligase is genetically controlled in rodent liver cancer and contributes to determine the susceptibility to the disease. Int J Cancer 2010; 126: 1275-1281.
11. Mato JM, Corrales FJ, Lu SC, Avila MA. S-Adenosylmethionine: a control switch that regulates liver function. FASEB J 2002; 16: 15-26.
12. Garcea R, Daino L, Pascale RM, Simile MM, Puddu M, Frassetto S. et al. Inhibition of promotion and persistent nodule growth by S-adenosyl-L-methionine in rat liver carcinogenesis: role of remodeling and apoptosis. Cancer Res 1989; 49: 1850-1856.
13. Pascale RM, Marras V, Simile MM, Daino L, Pinna G, Bennati S, et al. Chemoprevention of rat liver carcinogenesis by S-adenosyl-L-methionine: a long-term study. Cancer Res 1992; 52: 4979-4986.
14. Cai J, Mao Z, Hwang JJ, Lu SC. Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells. Cancer Res 1998; 58: 1444-1450.
15. Martinez-Chantar ML, Corrales FJ. Martinez-Cruz LA. Garcia-Trevijano ER. Huang ZZ, Chen L. et al. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J 2002; 16: 1292-1294.
16. Li J, Ramani K, Sun Z, Zee C, Grant EG, Yang H, et al. Forced expression of methionine adenosyltransferase 1A in human hepatoma cells suppresses in vivo tumorigenicity in mice. Am J Pathol 2010; 176: 2456-66.
17. Avila MA, Berasain C, Torres L, Martín-Duce A, Corrales FJ, Yang H, et al. Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol 2000; 33: 907-914.
18. Calvisi DF, Simile MM, Ladu S, Pellegrino R, De Murtas V, Pinna F, et al. Altered methionine metabolism and global DNA methylation in liver cancer: relationship with genomic instability and prognosis. Int J Cancer 2007; 121: 2410-2420.
19. Torres L, Avila MA, Carretero MV, Latasa MU, Caballería J, López-Rodas G, et al. Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation. FASEB J 2000; 14: 95-102.
20. Tomasi ML, Li TW, Li M, Mato JM, Lu SC. Inhibition of human methionine adsenosyltransferase 1A transcription by coding region methylation. J Cell Physiol 2012; 227: 1583-1591.
21. Yang H, Huang ZZ, Zeng Z, Chen C, Selby RR, Lu SC. Role of promoter methylation in increased methionine adenosyltransferase 2A expression in human liver cancer. Am J Physiol Gastrointest Liver Physiol 2001; 280: 184-190.
22. Vázquez-Chantada M, Fernández-Ramos D, Embade N, Martínez-Lopez N, Varela-Rey M, Woodhoo A, et al. HuR/methyl-HuR and AUF1 regulate the MAT expressed during liver proliferation, differentiation, and carcinogenesis. Gastroenterology. 2010; 138: 1943-1953.
23. Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Life Sci 2001, 58: 266-277.
24. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 2004; 23: 3092-3102
25. Solt, DB, Medline, A, Farber, E. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am J Pathol 1977; 88: 595-618.
26. Balaghi M, Wagner C. DNA methylation in folate deficiency: use of CpG methylase. Biochem Biophys Res Commun 1993; 193: 1184-1190.
27. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990-1997.
28. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997; 25: 2532-2534.
29. Galm O, Rountree MR, Bachman KE, Jair KW, Baylin SB, Herman JG. Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation density. Genome Res 2002; 12: 153-157.
30. Mohn F, Weber M, Schübeler D, Roloff TC. Methylated DNA immunoprecipitation (MeDIP). Methods Mol Biol 2009; 507: 55-64.
31. Goto Y, Gomez M, Brockdorff N, Feil R. Differential patterns of histone methylation and acetylation distinguish active and repressed alleles at X-linked genes. Cytogenet Genome Res 2002; 99: 66-74.
32. Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA. Reversible cross-linking combine with immunoprecipitation to study mRNA-protein interaction in vivo. Methods 2002; 26: 182-190.
33. Sakamoto M. Early HCC: diagnosis and molecular markers. J Gastroenterol 2009; 44( Suppl XIX): 108-111.
34. Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 2005; 5: 223-231.
35. Moon MK, Kim M, Chung SS, Lee HJ, Koh SH, Svovoda P, et al. S-Adenosyl-L-methionine ameliorates TNFalpha-induced insulin resistance in 3T3-L1 adipocytes. Exp Mol Med 2010; 42: 345-352.
36. García-Román R, Salazar-González D, Rosas S, Arellanes-Robledo J, Beltrán-Ramírez O, Fattel-Fazenda S, et al. The differential NF-κB modulation by S-adenosyl-L-methionine, N-acetylcysteine and quercetin on the promotion stage of chemical hepatocarcinogenesis. Free Radic Res 2008; 42: 331-343.
37. Ikeda R, Nishida T, Watanabe F, Shimizu-Saito K, Asahina K, Horikawa S, et al. Involvement of CCAAT/enhancer binding protein-β (C/EBPβ) in epigenetic regulation of mouse methionine adenosyltransferase 1A gene expression. Int J Biochem Cell Biol 2008: 40: 1956-1969.
38. Kashiwagi K, Nimura K, Ura K, Kaneda Y. DNA methyltransferase 3b preferentially associates with condensed chromatin. Nucleic Acids Res 2011; 39: 874-888.
39. Fuks F, Burgers WA, Godin N, Kasai M, Kouzarides T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J 2001; 20: 2536-2544.
40. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007; 16: R50-R59.
41. Feo F, Frau M, Tomasi ML, Brozzetti S, Pascale RM. Genetic and epigenetic control of molecular alterations in hepatocellular carcinoma. Exp Biol Med 2009; 234: 726-36.
42. Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, et al. Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis 2004; 25: 333-341.
43. Naugler WE, Karin M. NF-κB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 2008; 18: 19-26.
44. Majano PL, García-Monzón C, García-Trevijano ER, Corrales FJ, Cámara J, Ortiz P, et al. S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol 2001; 35: 692-699.
45. Tomasi ML, Iglesias-Ara A, Yang H, Ramani K, Feo F, Pascale RM. et al. S-Adenosylmethionine regulates apurinic/apyrimidinic endonuclease 1 stability: implication in hepatocarcinogenesis. Gastroenterology 2009; 136: 1025-1036.